Rafael Holdings (RFL) stock

Worth $107.00Shares as of Mar 12

$1.07

-0.93%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score RFL. It is too thinly traded for a fair Quality Score.

Healthcare · Pharma

NextDec 27, 2026 · In 47 days“…2026 Phase 3 topline data reported Oct. 2026 NDA submitted to FDA Dec. 27, 2026 Day 60 FDA filing…”Filing with regulators · SEC filing · Nov 9

Cash$22.1M, about 2 quarters at the last year's spendingOn Jul 31

Follow RFL's news. Pro members can get an alert when Rafael Holdings files news, and see its trials, share raises, and its CEO's filings.

Get an alert when RFL files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$22.1M, about 2 quarters at the last year's spendingOn Jul 31

What's next for RFL, and how long its cash lasts

Next step the company has named

Dec 27In 47 days“…with FDA on 48 - week data June 2026 Phase 3 last patient, last visit Sept. 2026 Phase 3 topline data reported Oct. 2026 NDA submitted to FDA Dec. 27, 2026 Day 60 FDA filing decision.”Filing with regulators · SEC filing · Nov 9

What it means: a filing asks regulators to approve a drug for sale. Once it is complete and accepted, the FDA sets a decision date, and we show it here.

For Pro members: 1 more milestone and 41 filings.

Cash runway Jul 31 balance sheet

About 2 quarters

$22.1M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Apr 18, 2025)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Howard Jonas buys or sells

For Pro members: every trade, and Howard Jonas’s 15 filings and quotes.

Get an alert when RFL files newsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

RFL's latest filings

An update to investors8-K, filed Nov 9
Annual report10-K, filed Oct 29
An insider's trade or awardForm 4, filed Oct 27

24 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why RFL isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. RFL trades about 62,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.